European Antibody Congress

Venue: Crowne Plaza

Location: Geneva, Switzerland

Event Date/Time: Nov 30, 2009 End Date/Time: Dec 02, 2009
Registration Date: Nov 30, 2009
Early Registration Date: Sep 11, 2009
Report as Spam


Europe’s largest commercial antibodies event designed for the world’s leading business and scientific leaders and dedicated to the future development of the antibodies market in Europe and beyond.

* Where the future of the antibody industry will be decided
Europe’s largest forum for the advancement of antibody discovery and development

* A content driven agenda tackling the industries biggest issues
The most impressive mix of expert speakers from global pharmaceutical companies, cutting edge biotechs, research organisations and academia

* Focused on bringing partners together
Build new relationships and future partnerships with more hours of dedicated networking than any other antibody event

Key speaker include

* Dr Alain Beck, Head of Physio-Chemistry Department, Centre d’Immunologie Pierre Fabre
* Dr Paul Parren, Senior Vice President, Research and Development, GenMab
* Dr Nils Lonberg, Senior Vice President and Scientific Director, Medarex
* Dr Janice Reichert, Senior Research Fellow, Tufts Center for the Study of Drug Development and Editor-in-Chief, mAbs
* Dr Nathalie Corvaïa, Head of Research, Centre d’Immunologie Pierre Fabre
* Dr Robert Lutz, Executive Director, ImmunoGen
* Dr Tony Maschio, Partner, Life Sciences and European Patent Attorney, Edwards, Angell, Palmer & Dodge LLP
* Professor Stefan Dübel, Director, Department of Biotechnology, University of Braunschweig, Germany
* Dr Iqbal Grewal, Vice President, Preclinical Therapeutics, Seattle Genetics
* Dr Eric Ezan, Head, Pharmacology and Immuanalytics, CEA
* Dr Stephen Demarest, Senior Scientist, Department of Protein Chemistry, Biogen Idec
* Dr Debbie Law, Chief Scientific Officer, Ablynx

Please visit the website for full programme and speaker details.